Startups
ArrePath
Princeton biotechnology company using AI, machine learning and experimental chemistry to discover oral small-molecule drugs. Its platform develops target-specific models to optimize activity and developability together. Initially proven in antibacterial discovery, the company is expanding into immunology and inflammation while seeking partners for its legacy antibiotic programs.
Team
 Alita MillerChief Scientific Officer |
 Diego MirallesChairman of the Board |
 Dylan MorrisBoard Member |
 Kevin KrausePresident and Chief Executive Officer · Board Member |
 Kurt ThornChief Technology Officer |
 Matthias SamwerBoard Member |
 Venkat SrinivasanBoard Member |
 Zemer GitaiFounder, Scientific Advisory Board Chair and Board Member |